A massive backlog of maintenance and software contracts will ensure recurring revenue.
Source: https://www.marketwatch.com/story/iran-strikes-will-likely-b…
Donald Trump signed an executive order on Dec. 18 to fast-track the Food and Drug Administration’s review to reclassify cannabis as a Schedule III substance under the Controlled Substances Act. Pot stocks Trulieve Cannabis, Curaleaf, Cresco Labs, Green Thumb Industries, and Canopy Growth plummeted by up to 39% due to the scope of Trump’s intentions.
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Companies that were expecting cheaper capital to fund their AI investing efforts might now have to operate with greater efficiency. Higher-for-longer interest rates could pressure market sentiment, which can hurt valuations of AI stocks in different ways.
